You are leaving PADCEV.com
By clickingtapping "Go to link" below, you are leaving an Astellas, Inc. and Seattle Genetics, Inc. website. Astellas, Inc. and Seattle Genetics, Inc. are not responsible for the information or services on any third-party sites.
This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by Astellas Inc. and/or Seattle Genetics, Inc. of the site, its contents, or the owner of the site. Please review the privacy policy and terms of use of the site to understand how your information will be processed.
Thank you for visiting our site.
PADCEV Support Solutions℠
is here to help
PADCEV Support Solutions℠ offers access and reimbursement support to help patients like you, who have been prescribed PADCEV™, access their medication.
PADCEV Support Solutions℠ offers access and reimbursement support to help patients like you, who have been prescribed PADCEV™, access their medication.
Call PADCEV Support Solutions at 1-888-402-0627 Monday-Friday, 8:30 AM to 8:00 PM ET or visit the PADCEV Support Solutions website if you have any questions or need assistance.
Call PADCEV Support Solutions at 1-888-402-0627 Monday-Friday, 8:30 AM to 8:00 PM ET or visit the PADCEV Support Solutions website if you have any questions or need assistance.
We Can Help Evaluate Your Insurance Coverage
PADCEV Support Solutions offers information to help you understand your insurance
coverage for PADCEV. PADCEV Support Solutions will provide your doctor with a summary of your
insurance benefits. We can also help determine if your insurer requires a prior authorization (PA). If your
insurer denies a PA request, and your doctor determines that an appeal is appropriate, PADCEV Support
Solutions can assist with the appeal.
PADCEV Support Solutions Offers Patient Assistance Options and Financial Assistance Information
Copay Assistance Program
The PADCEV Copay Assistance Program is for eligible patients who have private commercial health insurance and are not insured by any federal or state healthcare program. Eligible patients pay as little as $5 per dose and are enrolled in the program for 12 months. Under the program, eligible patients may save up to a maximum of $25,000 per calendar year. There are no income requirements.a
Patient Assistance Program
The PADCEV Patient Assistance Program provides PADCEV at no cost to uninsured patients who meet the program eligibility requirements.b
Financial Assistance Information
For patients who need financial assistance to help cover out-of-pocket costs, PADCEV Support Solutions can provide information about other sources of support that may be able to help.
a In order to participate in the PADCEV Copay Assistance Program (“Program”), a patient must have private commercial insurance for PADCEV. The Program is not valid for patients insured by any federal or state healthcare program, including, but not limited to, Medicaid, Medicare, Medigap, Department of Defense (DoD), Veterans Affairs (VA), TRICARE, Puerto Rico Government Insurance, or any state patients or pharmaceutical assistance program. This offer is not valid for cash-paying patients. This Program is void where prohibited by law. Astellas reserves the right to revoke, rescind, or amend this offer without notice. The Program benefits are nontransferable. This Program is not conditioned on any past, present, or future purchase, including additional doses. The benefit available under this Program is valid only for the patient’s out-of-pocket medication costs for PADCEV. The benefit is not valid for any other out-of-pocket costs such as medication administration charges or other healthcare provider services. The Program is Not Insurance.
b Subject to eligibility. Void where prohibited by law.
Patient Connect
PADCEV Support Solutions, through the Patient Connect Program, offers additional patient and caregiver support to people like you who have been prescribed PADCEV. This program helps connect you and your loved ones to educational resources and support based on your particular needs to help you manage your disease and daily life while on treatment.
When you call PADCEV Support Solutions, a trained representative will speak with you to understand the types of challenges you may be facing and will customize a search of various independent local and national organizationsc that may provide support and resources right for you and your loved ones. Examples may include:
Emotional Support
Logistical Support
Informational Support
c Support is provided through third-party organizations that operate independently and are not controlled or endorsed by Astellas or Seattle Genetics. Availability of support and eligibility requirements are determined by these organizations.
Call PADCEV Support Solutions at 1-888-402-0627 Monday-Friday, 8:30 AM to 8:00 PM ET or visit the PADCEV Support Solutions website if you have any questions or need assistance.
Call PADCEV Support Solutions at 1-888-402-0627 Monday-Friday, 8:30 AM to 8:00 PM ET or visit the PADCEV Support Solutions website if you have any questions or need assistance.
IMPORTANT SAFETY INFORMATION
Before receiving PADCEV, tell your healthcare provider about all of your medical conditions, including if you:
• are currently experiencing numbness or tingling in your hands or feet
• have a history of high blood sugar or diabetes
• are pregnant or plan to become pregnant. PADCEV can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with PADCEV
• are breastfeeding or plan to breastfeed. It is not known if PADCEV passes into your breast milk. Do not breastfeed during treatment and for at least 3 weeks after the last dose of PADCEV
Females who are able to become
pregnant:
• Your healthcare provider should do a pregnancy test before you start treatment with PADCEV.
• You should use an effective method of birth control during your treatment and for at least 2 months after the last dose of PADCEV.
Males with a female sexual partner
who is able to become pregnant:
• If your female partner is pregnant, PADCEV can harm the unborn baby.
• You should use an effective method of birth control during your treatment and for at least 4 months after the last dose of PADCEV.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How will you receive PADCEV?
• PADCEV will be given to you by intravenous (IV) infusion into your vein over 30 minutes.
• You will receive your PADCEV over periods of time called cycles.
- Each PADCEV cycle is 28 days.
- You will receive PADCEV on days 1, 8 and 15 of every cycle.
• Your healthcare provider will decide how many treatment cycles you need.
• Your healthcare provider may do blood tests regularly during treatment with PADCEV.
What are the possible side effects of PADCEV?
PADCEV may cause serious side effects including:
• High Blood Sugar (hyperglycemia). You can develop high blood sugar during treatment with PADCEV. Tell your healthcare provider right away if you have any symptoms of high blood sugar, including: frequent urination, increased thirst, blurred vision, confusion, it becomes harder to control your blood sugar, drowsiness, loss of appetite, fruity smell on your breath, nausea, vomiting, or stomach pain.
• Peripheral neuropathy. While receiving PADCEV you may experience nerve problems called peripheral neuropathy. Tell your healthcare provider right away if you experience numbness or tingling in your hands or feet, or muscle weakness.
• Eye problems. You can develop certain eye problems while receiving PADCEV. Tell your healthcare provider right away if you have dry eyes or blurred vision.
• Skin reactions. Rashes and severe skin reactions can happen while receiving PADCEV. Tell your healthcare provider right away if you get a rash or a skin reaction that continues to get worse.
• Leakage of PADCEV out of your vein into the tissues around your infusion site (extravasation). If PADCEV leaks from the injection site or the vein into the nearby skin and tissues, it could cause an infusion site reaction. These reactions can happen right after you receive an infusion, but sometimes may happen days after your infusion. Tell your healthcare provider or get medical help right away if you notice any redness, swelling, itching, or discomfort at the infusion site.
The most common side effects of PADCEV
include:
• numbness or tingling in your hands or feet, or muscle weakness
• fatigue
• decreased appetite
• rash
• hair loss
• nausea
• diarrhea
• change in sense of taste
• dry eyes
• dry skin
If you have certain side effects, your healthcare provider may decrease your dose or stop your treatment with PADCEV for a period of time (temporarily) or completely.
PADCEV may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.
These are not all the possible side effects of PADCEV.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information.
WHAT IS PADCEV™?
PADCEV (enfortumab vedotin-ejfv) is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. PADCEV may be used if you have received an immunotherapy medicine and also received a chemotherapy-containing platinum medicine. It is not known if PADCEV is safe and effective in children.
PADCEV was FDA-approved based on a clinical study that measured how many patients had a tumor response. There is another study with PADCEV to confirm the clinical benefit.
Please click here for full Prescribing Information.
IMPORTANT SAFETY INFORMATION
Before receiving PADCEV, tell your healthcare provider about all of your medical conditions, including if you:
• are currently experiencing numbness or tingling in your hands or feet
• have a history of high blood sugar or diabetes
• are pregnant or plan to become pregnant. PADCEV can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with PADCEV
• are breastfeeding or plan to breastfeed. It is not known if PADCEV passes into your breast milk. Do not breastfeed during treatment and for at least 3 weeks after the last dose of PADCEV
Females who are able to become
pregnant:
• Your healthcare provider should do a pregnancy test before you start treatment with PADCEV.
• You should use an effective method of birth control during your treatment and for at least 2 months after the last dose of PADCEV.
Males with a female sexual partner
who is able to become pregnant:
• If your female partner is pregnant, PADCEV can harm the unborn baby.
• You should use an effective method of birth control during your treatment and for at least 4 months after the last dose of PADCEV.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How will you receive PADCEV?
• PADCEV will be given to you by intravenous (IV) infusion into your vein over 30 minutes.
• You will receive your PADCEV over periods of time called cycles.
- Each PADCEV cycle is 28 days.
- You will receive PADCEV on days 1, 8 and 15 of every cycle.
• Your healthcare provider will decide how many treatment cycles you need.
• Your healthcare provider may do blood tests regularly during treatment with PADCEV.
What are the possible side effects of PADCEV?
PADCEV may cause serious side effects including:
• High Blood Sugar (hyperglycemia). You can develop high blood sugar during treatment with PADCEV. Tell your healthcare provider right away if you have any symptoms of high blood sugar, including: frequent urination, increased thirst, blurred vision, confusion, it becomes harder to control your blood sugar, drowsiness, loss of appetite, fruity smell on your breath, nausea, vomiting, or stomach pain.
• Peripheral neuropathy. While receiving PADCEV you may experience nerve problems called peripheral neuropathy. Tell your healthcare provider right away if you experience numbness or tingling in your hands or feet, or muscle weakness.
• Eye problems. You can develop certain eye problems while receiving PADCEV. Tell your healthcare provider right away if you have dry eyes or blurred vision.
• Skin reactions. Rashes and severe skin reactions can happen while receiving PADCEV. Tell your healthcare provider right away if you get a rash or a skin reaction that continues to get worse.
• Leakage of PADCEV out of your vein into the tissues around your infusion site (extravasation). If PADCEV leaks from the injection site or the vein into the nearby skin and tissues, it could cause an infusion site reaction. These reactions can happen right after you receive an infusion, but sometimes may happen days after your infusion. Tell your healthcare provider or get medical help right away if you notice any redness, swelling, itching, or discomfort at the infusion site.
The most common side effects of PADCEV
include:
• numbness or tingling in your hands or feet, or muscle weakness
• fatigue
• decreased appetite
• rash
• hair loss
• nausea
• diarrhea
• change in sense of taste
• dry eyes
• dry skin
If you have certain side effects, your healthcare provider may decrease your dose or stop your treatment with PADCEV for a period of time (temporarily) or completely.
PADCEV may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.
These are not all the possible side effects of PADCEV.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information.
WHAT IS PADCEV™?
PADCEV (enfortumab vedotin-ejfv) is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. PADCEV may be used if you have received an immunotherapy medicine and also received a chemotherapy-containing platinum medicine. It is not known if PADCEV is safe and effective in children.
PADCEV was FDA-approved based on a clinical study that measured how many patients had a tumor response. There is another study with PADCEV to confirm the clinical benefit.
Please click here for full Prescribing Information.
IMPORTANT SAFETY INFORMATION
Before receiving PADCEV, tell your healthcare provider about all of your medical conditions, including if you:
• are currently experiencing numbness or tingling in your hands or feet
• have a history of high blood sugar or diabetes
• are pregnant or plan to become pregnant. PADCEV can harm your unborn baby. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with PADCEV
• are breastfeeding or plan to breastfeed. It is not known if PADCEV passes into your breast milk. Do not breastfeed during treatment and for at least 3 weeks after the last dose of PADCEV
Females who are able to become
pregnant:
• Your healthcare provider should do a pregnancy test before you start treatment with PADCEV.
• You should use an effective method of birth control during your treatment and for at least 2 months after the last dose of PADCEV.
Males with a female sexual partner
who is able to become pregnant:
• If your female partner is pregnant, PADCEV can harm the unborn baby.
• You should use an effective method of birth control during your treatment and for at least 4 months after the last dose of PADCEV.
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
How will you receive PADCEV?
• PADCEV will be given to you by intravenous (IV) infusion into your vein over 30 minutes.
• You will receive your PADCEV over periods of time called cycles.
- Each PADCEV cycle is 28 days.
- You will receive PADCEV on days 1, 8 and 15 of every cycle.
• Your healthcare provider will decide how many treatment cycles you need.
• Your healthcare provider may do blood tests regularly during treatment with PADCEV.
What are the possible side effects of PADCEV?
PADCEV may cause serious side effects including:
• High Blood Sugar (hyperglycemia). You can develop high blood sugar during treatment with PADCEV. Tell your healthcare provider right away if you have any symptoms of high blood sugar, including: frequent urination, increased thirst, blurred vision, confusion, it becomes harder to control your blood sugar, drowsiness, loss of appetite, fruity smell on your breath, nausea, vomiting, or stomach pain.
• Peripheral neuropathy. While receiving PADCEV you may experience nerve problems called peripheral neuropathy. Tell your healthcare provider right away if you experience numbness or tingling in your hands or feet, or muscle weakness.
• Eye problems. You can develop certain eye problems while receiving PADCEV. Tell your healthcare provider right away if you have dry eyes or blurred vision.
• Skin reactions. Rashes and severe skin reactions can happen while receiving PADCEV. Tell your healthcare provider right away if you get a rash or a skin reaction that continues to get worse.
• Leakage of PADCEV out of your vein into the tissues around your infusion site (extravasation). If PADCEV leaks from the injection site or the vein into the nearby skin and tissues, it could cause an infusion site reaction. These reactions can happen right after you receive an infusion, but sometimes may happen days after your infusion. Tell your healthcare provider or get medical help right away if you notice any redness, swelling, itching, or discomfort at the infusion site.
The most common side effects of PADCEV
include:
• numbness or tingling in your hands or feet, or muscle weakness
• fatigue
• decreased appetite
• rash
• hair loss
• nausea
• diarrhea
• change in sense of taste
• dry eyes
• dry skin
If you have certain side effects, your healthcare provider may decrease your dose or stop your treatment with PADCEV for a period of time (temporarily) or completely.
PADCEV may cause fertility problems in males, which may affect the ability to father children. Talk to your healthcare provider if you have concerns about fertility.
These are not all the possible side effects of PADCEV.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for full Prescribing Information.
WHAT IS PADCEV™?
PADCEV (enfortumab vedotin-ejfv) is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. PADCEV may be used if you have received an immunotherapy medicine and also received a chemotherapy-containing platinum medicine. It is not known if PADCEV is safe and effective in children.
PADCEV was FDA-approved based on a clinical study that measured how many patients had a tumor response. There is another study with PADCEV to confirm the clinical benefit.
Please click here for full Prescribing Information.
© 2020 Astellas Pharma US, Inc. and Seattle Genetics, Inc. All rights reserved. -PM /20
PADCEV and the PADCEV logo are trademarks jointly owned by Agensys, Inc. and Seattle Genetics, Inc.
Astellas and the flying star logo are registered trademarks of Astellas Pharma Inc.
Seattle Genetics and the Seattle Genetics logo are registered trademarks of Seattle Genetics, Inc.
© 2020 Astellas Pharma US, Inc. and Seattle Genetics, Inc. All rights reserved. -PM /20
PADCEV and the PADCEV logo are trademarks jointly owned by Agensys, Inc. and Seattle Genetics, Inc.
Astellas and the flying star logo are registered trademarks of Astellas Pharma Inc.
Seattle Genetics and the Seattle Genetics logo are registered trademarks of Seattle Genetics, Inc.
© 2020 Astellas Pharma US, Inc. and Seattle Genetics, Inc. All rights reserved. -PM /20
PADCEV and the PADCEV logo are trademarks jointly owned by Agensys, Inc. and Seattle Genetics, Inc.
Astellas and the flying star logo are registered trademarks of Astellas Pharma Inc.
Seattle Genetics and the Seattle Genetics logo are registered trademarks of Seattle Genetics, Inc.
© 2020 Astellas Pharma US, Inc. and Seattle Genetics, Inc. All rights reserved. -PM /20
PADCEV and the PADCEV logo are trademarks jointly owned by Agensys, Inc. and Seattle Genetics, Inc.
Astellas and the flying star logo are registered trademarks of Astellas Pharma Inc.
Seattle Genetics and the Seattle Genetics logo are registered trademarks of Seattle Genetics, Inc.
